Publications

MPS Authors Authors in order Year Title Journal
Anne Whitehead Higgins, J. P. T., Lane, P. W., Anagnostelis, B., Anzures-Cabrera, J., Baker, N. F., Cappelleri, J. C., Haughie, S., Hollis, S., Lewis, S. C., Moneuse, P., Whitehead, A. 2013 A tool to assess the quality of a meta-analysis. Research Synthesis Methods. 4:351-366.
Alice Parry, Thomas Jaki Jaki, T., Parry, A., Winter, K., Hastings, I. 2013 Analysing malaria drug trials on a per individual or a per clone basis: A comparison of methods. Statistics in Medicine. 32(17), 3020-3038.
Thomas Jaki Jaki, T. 2013 Uptake of novel statistical methods for early phase clinical studies in the UK public sector Clinical Trials. 10, 344-346.
Thomas Jaki Wason, J. M. S., Jaki, T., Stallard, N. 2013 Planning multi-arm screening studies within the context of a drug development programme Statistics in Medicine. 32(20):3424-3435.
Thomas Jaki George, M., Yang, N., Van Horn, M. L., Smith J., Jaki, T., Feaster, D., Masyn, K., Howe, G. 2013 Using regression mixture models with non-normal data: Examining an ordered polytomous approach Journal of Statistical Computation and Simulation. 83(4):757-770.
Thomas Jaki Jaki, T., Pallmann, P., Wolfsegger, M. J. 2013 Estimation in AB/BA cross-over trials with application to bioequivalence studies with incomplete and complete data designs Statistics in Medicine. 32(30):5469-5483
Thomas Jaki George, M., Yang, N., Jaki, T., Feaster, D., Smith, J., Van Horn, M. L. 2013 Finite mixtures for simultaneously modelling differential effects and non-normal distributions Multivariate Behavioral Research. Accepted.
Thomas Jaki Wolfsegger, M. J., Gutjahr, G., Engl, W., Jaki, T. 2013 A hybrid method to estimate the minimum effective dose for monotone and non-monotone dose-response relationships Biometrics.
Anne Whitehead Sarker, S-J., Whitehead, A., Khan, I. 2013 A C++ program to calculate sample sizes for cost-effectiveness trials in a Bayesian framework Computer Methods and Programs in Biomedicine. 110:471-489.
Anne Whitehead Lane, P. W., Higgins, J. P. T., Anagnostelis, B., Anzures-Cabrera, J., Baker, N. F., Cappelleri, J. C., Haughie, S., Hollis, S., Lewis, S. C., Moneuse, P., Whitehead, A. 2013 Methodological quality of meta-analyses: Comparisons over time and between industry-sponsored and academic-sponsored reports Research Synthesis Methods. 4:342-350.
Dominic Magirr, Thomas Jaki Jaki, T., Magirr, D. 2013 Considerations on covariates and endpoints in multi-arm multi-stage clinical trials selecting all promising treatments Statistics in Medicine. 32(7), 1150-1163.
Anne Whitehead, Helene Thygesen, Matthew Sperrin, Ting-Li Su Whitehead, A., Su, T-L., Thygesen, H., Sperrin, M., Harbron, C. 2013 Investigation of the robustness of two models for assessing synergy in pre-clinical drug combination studies Pharmaceutical Statistics.12, 300-308.
Thomas Jaki Jaki, T., Clive, S., Weir, C. 2013 Principles of dose finding studies in cancer: A comparison of popular methods Cancer Chemotherapy and Pharmacology; 71, 1107-1114.
Thomas Jaki Jaki, T., Hothorn, L. A. 2013 Statistical evaluation of toxicological assays: Dunnett or Williams test? − take both Archives of Toxicology. 87(11):1901-1910.
John Whitehead, Thomas Jaki, Ting-Li Su Jaki, T., Andre, V., Su, T-L., Whitehead, J. 2013 Designing exploratory cancer trials using change in tumour size as primary endpoint Statistics in Medicine. 32(15):2544-2554.
Dominic Magirr, Thomas Jaki Magirr, D., Jaki, T., Posch, M., Klingelmueller, F. 2013 Simultaneous confidence intervals that are compatible with closed testing in adaptive designs Biometrika. 100(4):985-996.
Thomas Jaki Phillips, A., Fletcher, C., Atkinson, G., Channon, E., Douiri, A., Jaki, T., Maca, J., Morgan, D., Roger, J., Terrill, P. 2013 Multiplicity: Discussion points from the PSI Multiplicity Expert Group. Pharmaceutical Statistics. 12(5):255-259.
Matthew Sperrin Sperrin, M., Buchan I. 2013 Modelling time to event with observations made at arbitrary times Statistics in Medicine. 32(1), 99-109.
Anne Whitehead, Helene Thygesen, Matthew Sperrin, Ting-Li Su Whitehead, A., Su, T-L., Thygesen, H., Sperrin, M., Harbron, C. 2013 Investigation of the robustness of two models for assessing synergy in pre-clinical drug combination studies Pharmaceutical Statistics. 12:300-308.
Thomas Jaki Fagan, A., Van Horn, M. L., Hawkins, J. D., Jaki, T. 2013 Differential Effects of Parental Controls on Adolescent Substance Use: For Whom Is the Family Most Important? Journal of Quantitative Criminology. 29:347-368.

Pages